Home
Press Releases
SEC Filings
Events
FAQs
Annual Reports
Fact Sheet
Management Team
Code of Ethics
Board of Directors
Contact Us

[2008 Archive] [2007 Archive] [2006 Archive] [2005 Archive] [2004 Archive] [2003 Archive]

 

 

12/26/2006--
Columbia Laboratories Closes $40 Million Private Placement Of Convertible Subordinated Notes And Completes Acquisition Of U.S. Marketing Rights To Crinone® Progesterone Gel
 

12/22/2006--
Columbia Laboratories Completes Treatment Phase Of Phase III Study Of Prochieve 8% To Prevent Recurrent Preterm Birth

 

12/22/2006--

Columbia Laboratories To Raise $40 Million Through Private Placement Of Convertible Subordinated Notes
 

12/07/2006--
James Meer Appointed Chief Financial Officer Of Columbia Laboratories
 

11/09/2006--
Columbia Laboratories Reports Third Quarter 2006 Financial Results
 

11/07/2006--
Columbia Laboratories Advances Clinical Development of Lidocaine Candidate
 

10/26/2006--
Columbia Laboratories to Present at Rodman & Renshaw Healthcare Conference in NYC
 

10/23/2006--
Columbia Laboratories Comments on FDA Decision on Adeza’s Gestiva
 

10/23/2006--
Columbia Laboratories to Discuss Third Quarter 2006 Financial Results on November 9, 2006
 

08/29/2006--
Columbia Laboratories Comments on FDA Reproductive Drugs Advisory Committee Recommendation on 17-OHPC
 

08/09/2006 --
Columbia Laboratories Reports Second Quarter 2006 Financial Results
 

08/07/2006 --
Columbia Laboratories to Present at Roth Capital Partners Equity Conference in NYC on September 6, 2006
 

08/01/2006 --
Columbia Labs Completes Enrollment in Pivotal Phase III Study of Prochieve 8% to Prevent Preterm Birth
 

07/31/2006 --
Columbia Laboratories to Discuss 2Q 2006 Financial Results on August 9, 2006 Conference Call
 

06/01/2006 --
Columbia Laboratories to Present at FTN Midwest Securities Health Care Conference in NYC
 

05/15/2006 --
Columbia Laboratories Added To NASDAQ Biotechnology Index
 

05/09/2006 --
Columbia Laboratories Reports First Quarter 2006 Financial Results
 

05/02/2006 --
Columbia Laboratories to Discuss First Quarter 2006 Financial Results on May 9, 2006 Conference Call
 

03/14/2006 --
Columbia Laboratories closes $30 Million Private Placement
 

03/13/2006 --
Columbia Laboratories To Raise $30 Million Through Private Placement Of Common Stock And Warrants
 

03/07/2006 --
Columbia Laboratories Reports Fourth Quarter and Year-End 2005 Financial Results
 

03/07/2006 --
Robert S. Mills Elected Chief Executive Officer of Columbia Laboratories
 

02/24/2006 --
Columbia Laboratories to Discuss Fourth Quarter and Year End 2005 Financial Conference Call
 

01/09/2006 --
Columbia Laboratories announces management changes